Triple-negative breast cancer (TNBC) is a particularly aggressive subtype of breast cancer characterized by the absence of estrogen receptors, progesterone receptors, and overexpression of human epidermal growth factor receptor 2 (HER2) limiting treatment options. This evidence concerns the gene ERBB2 and breast carcinoma.